Heart failure (HF) is a major public health problem, and it is associated with increased
morbidity and mortality. As the US life expectancy increases and the population ages, the …

Because of rapid advances in the treatment of chronic heart failure, four important
guidelines, including those from the European Society of Cardiology, have recently been …

Increasing knowledge of the processes leading to heart failure (HF) has allowed significant
developments in therapies for HF over the past few decades. Despite the evolution of HF …

Over the past several decades, important advances have been made in the treatment of
patients with heart failure (HF). Whereas in the past, the main goal of drug therapy was to …

Congestive heart failure (HF) is a morbidity that is increasing worldwide due to the aging
population and improvement in (acute) care for patients with cardiovascular diseases. The …

Over the last several years there have been significant advances in the management of
chronic heart failure, encompassing developments in pharmacotherapy and device-based …

The ACC, the AHA, and the Heart Failure Society of America (HFSA) recognize that the
introduction of effective new therapies that potentially affect a large number of patients …

The number of hospitalizations for heart failure has continued to increase despite rapid and
significant advances in cardiovascular care. The mortality rate is lower, but morbidity …

Several life-prolonging therapies are available for the treatment of heart failure, yet they are
underutilized in many patients. A treatment gap exists between patients who are eligible for …

Heart failure (HF) is a major problem of public health. More than 23 million patients
worldwide are affected by heart failure. Despite incidence and prevalence of heart failure …